The successful application of ACC technology in cancer treatment was demonstrated by the specific cancer antigen recognition and superior anti-cancer potency of antibody-armed immune cells [20], leading to a clinical trial for HER2-expressing tumors. This evidence concerns the gene ERBB2 and cancer.